Oregon Public Employees Retirement Fund Purchases 35,615 Shares of CVS Health Corporation $CVS

Oregon Public Employees Retirement Fund raised its holdings in shares of CVS Health Corporation (NYSE:CVS) by 32.6% during the third quarter, Holdings Channel.com reports. The fund owned 145,027 shares of the pharmacy operator’s stock after buying an additional 35,615 shares during the period. Oregon Public Employees Retirement Fund’s holdings in CVS Health were worth $10,934,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in CVS. Cantor Fitzgerald Investment Advisors L.P. lifted its stake in CVS Health by 1.6% in the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after purchasing an additional 6,615 shares in the last quarter. Alpha Omega Wealth Management LLC increased its holdings in shares of CVS Health by 12.3% in the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock worth $11,301,000 after purchasing an additional 16,418 shares during the last quarter. Aaron Wealth Advisors LLC lifted its position in shares of CVS Health by 177.4% in the third quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator’s stock worth $2,583,000 after buying an additional 21,911 shares in the last quarter. Red Mountain Financial LLC bought a new position in CVS Health during the second quarter valued at approximately $293,000. Finally, Osaic Holdings Inc. grew its holdings in CVS Health by 18.4% during the 2nd quarter. Osaic Holdings Inc. now owns 229,903 shares of the pharmacy operator’s stock valued at $15,828,000 after buying an additional 35,809 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 0.4%

Shares of CVS opened at $80.29 on Friday. The company’s fifty day simple moving average is $78.70 and its 200-day simple moving average is $73.83. The company has a market cap of $101.92 billion, a P/E ratio of 211.29, a P/E/G ratio of 0.74 and a beta of 0.48. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a twelve month low of $46.34 and a twelve month high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the prior year, the firm posted $1.09 EPS. The firm’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.3%. The ex-dividend date is Thursday, January 22nd. CVS Health’s dividend payout ratio is presently 700.00%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CVS. Evercore ISI upped their price objective on CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Leerink Partners boosted their price target on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th. UBS Group reiterated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Wall Street Zen cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Finally, Argus upped their target price on shares of CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $94.86.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.